Back

Emerald Clinical appoints Michael Stibilj CEO effective Oct. 1, 2026

Verifying
  • Emerald Clinical Trials appointed Michael Stibilj Chief Executive Officer.
  • 1 October 2026 marks the effective date of Stibilj's appointment.
  • Emerald's Hongyi acquisition created a platform spanning 40+ countries and 70+ locations.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.